Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Problematic has become outdated in relation with current litterature advances.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cytomegalovirus is a herpesviridae whose prevalence in general population is between 50 to 80%. In immunocompetent individuals, CMV remains latent in a number of cells, without any pathological consequence. Immunosuppression may reactivate the virus causing either a CMV-active infection or a CMV disease with attributable symptoms.
In Intensive Care Unit (ICU), 6 to 30 % of critically ill patients without classical immunosuppression, as those suffering from septic shock, present CMV reactivation. Our aim is to study the risk factors for developing viremia or CMV disease in ICU patients in septic shock without previous immunodepression and determine the relationship between viral reactivation and this acquired immunity alteration.
Immunosuppression statuses causing both CMV active infection or disease are mainly consecutive to HIV infection, bone marrow or solid organ transplantation. However, in severely ill patients, as in septic shock, it has been proved that after a hyper-inflammatory phase occurred a negative control of the immunity, resulting in a paralysed or impaired immune system. The length and extent of this immunodeficiency is correlated with the duration of ICU stay, the occurrence of nosocomial infection and mortality.
A better understanding of CMV's natural history reactivation in the critically ill patient would better define the benefits from a specific therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Septic shock patients | Septic shock patients staying over 3 days mechanically ventilated in the ICU |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of CMV disease | CMV disease is defined by occurence of viremia and/or an organ failure | From Day 3 of ICU admission to the end of their stay in ICU (in average, from 6 days to 4 weeks) |
| Measure | Description | Time Frame |
|---|---|---|
| Mortality | Day 28 | |
| Length of ICU stay | About 90 days | |
| Duration of mechanical ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients admitted in ICU for septic shock, without previous immunodepression, and who will stay in ICU for over 3 days, mechanically ventialted
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Universitary Hospital - Medical Intensive Care Station | Grenoble | 38043 | France |
Not provided
| ID | Term |
|---|---|
| D003586 | Cytomegalovirus Infections |
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D006566 | Herpesviridae Infections |
| D004266 | DNA Virus Infections |
| D014777 | Virus Diseases |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| About 90 days |
| Occurence of nosocomial infections | About 90 days |
| D018805 |
| Sepsis |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |